We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$93.5M
AUM Growth
–
Cap. Flow
+$86.6M
Cap. Flow %
92.64%
Top 10 Hldgs %
51.56%
Holding
120
New
112
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.63M
2
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$2.51M
3
CTO
CTO Realty Growth
CTO
+$1.68M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.55M
5
ORM
Owens Realty Mortgage, Inc.
ORM
+$1.46M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Real Estate 9.72%
2 Financials 6.23%
3 Industrials 5.78%
4 Communication Services 5.45%
5 Technology 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
101
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$35K 0.04%
+21,700
New +$394K
PRTK
102
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$34K 0.04%
+9,800
New +$127K
RCKT icon
103
PUT
Rocket Pharmaceuticals
RCKT
$343M
$28K 0.03%
+5,950
New +$170K
LCI
104
DELISTED
Lannett Company, Inc.
LCI
$12K 0.01%
+140
New +$12.9K
GNMX
105
PUT
DELISTED
Aevi Genomic Medicine Inc
GNMX
$12K 0.01%
+9,200
New +$48.4K
HZNP
106
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$12K 0.01%
+96,400
New +$1.75M
ROYT
107
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$11K 0.01%
+10,280
New +$14.1K
VGR
108
PUT
DELISTED
Vector Group Ltd.
VGR
$8K 0.01%
+67,902
New +$882K
ANIP icon
109
PUT
ANI Pharmaceuticals
ANIP
$1.84B
$7K 0.01%
+8,500
New +$520K
PRTK
110
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6K 0.01%
+900
New +$11.7K
ALR
111
DELISTED
Alere Inc
ALR
$6K 0.01%
+149
New +$6.03K
BCRX icon
112
PUT
BioCryst Pharmaceuticals
BCRX
$2.48B
$2K ﹤0.01%
+4,200
New +$21.9K
1 2 3 4
5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q4 2016 Portfolio in Review

Q4 2016 is the first quarter with a 13F filing on record for Worth Venture Partners, which disclosed 120 positions worth $93.5M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Vanguard Short-Term Corporate Bond ETF: 33,000 shares worth $2.62M.

By sector, the portfolio is most concentrated in Real Estate at 9.7% of assets, followed by Financials and Industrials.

  • Worth Venture Partners's largest Q4 2016 buy was Vanguard Short-Term Corporate Bond ETF: 33,000 shares worth $2.62M.
  • Worth Venture Partners's ten largest holdings make up 52% of its $93.5M portfolio in Q4 2016.
  • Worth Venture Partners disclosed 120 positions in Q4 2016, its first 13F filing on record.

Based on Worth Venture Partners's 13F filing for Q4 2016, filed 15 Feb 2017.